Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AEA Investors is a leading global private investment firm, founded in 1968 by the Rockefeller, Mellon, and Harriman family interests with S.G. Warburg & Co. The firm manages over $15–18 billion in assets and focuses on private equity, growth capital, and private debt investments primarily in the middle market across sectors such as industrials, consumer products/services, and healthcare services[4][5][8]. It is not itself a life sciences or healthcare product developer but has invested in companies within those sectors[5][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AEA Investors.